RECRUITING

A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overarching objective of this study is to make it easier for parents of children with medical complexity (CMC) to take care of their children after discharge home from the hospital and reduce the chance of post-hospitalization morbidity (meaning bad outcomes such as readmissions) after discharge. CMC, or those with multiple chronic conditions, progressive conditions, or technology dependence, are at high risk for post-hospitalization morbidity.

Official Title

A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Quick Facts

Study Start:2021-07-23
Study Completion:2025-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04867395

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * English or Spanish-speaking
  2. * Parent or legal guardian and primary caregiver of child who has medical complexity (defined by significant chronic conditions in ≥2 body systems, progressive conditions associated with decreased life expectancy, dependence on technology for \>6 months \[e.g., respiratory equipment, central lines, feeding tubes\], or progressive/metastatic malignancies) who was admitted to the acute or intensive care units
  3. * The individual's child is ≤18 years old
  4. * The individual's child was discharged home or is expected be discharged home on ≥1 daily medication.
  5. * Willingness to be randomized to intervention group
  6. * Willingness and ability to participate in study procedures
  1. * Caregiver \<18 years old
  2. * Poor visual acuity (\<20/50 corrected on Rosenbaum screener for in-person recruitment; by subject report for phone recruitment)
  3. * Self-reported hearing difficulty
  4. * Previously enrolled.

Contacts and Locations

Study Contact

Alexander F Glick, MD, MS
CONTACT
212-263-8198
alexander.glick@nyulangone.org

Principal Investigator

Alexander F Glick, MD, MS
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Alexander F Glick, MD, MS, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-23
Study Completion Date2025-09-30

Study Record Updates

Study Start Date2021-07-23
Study Completion Date2025-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Children With Medical Complexity (CMC)